Definitive Healthcare Corp. (DH) stock
DHNasdaqServices-Prepackaged SoftwareFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/3067% below fair value
$1.31+0.06 (+4.80%)
Close on Nov 13, 2026Market cap $139.84MP/E –Yield –
Definitive Healthcare price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Definitive Healthcare's price to sales ratio was 0.6× on Nov 11, 2026, against 1.3× a year earlier. Over the last 5 years it ranged from 0.3× to 13.6×, with a median of 1.9×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.6× | −0.7 |
| 2025 | Dec 31, 2025 | 1.3× | −0.2 |
| 2024 | Dec 31, 2024 | 1.5× | −3.5 |
| 2023 | Dec 29, 2023 | 4.9× | −0.2 |
| 2022 | Dec 30, 2022 | 5.2× | – |
See a number that looks wrong?